Acute Myocardial Infarction Study in Northeastern China

• Conditions: Acute Myocardial Infarction
• Interventions: Procedure: thrombolysis

• Registration Number: NCT04451967
• Lead Sponsor: Second Hospital of Jilin University

Brief Summary

This is a real-world prospective cohort study aiming to generate knowledge about the characteristics, treatments, and outcomes of hospitalized AMI patients in Jilin Province. The study includes hospitalizations diagnosed of AMI, including ST segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI).

Detailed Description

Not available

Study Timeline

• Study Start: 2019-09-09
• Status Verified: 2020-06
• Study First Submitted: 2020-06-26
• Study First Submitted QC: 2020-06-29
• Last Update Submitted: 2020-06-29
• Study First Posted: 2020-06-30
• Last Update Posted: 2020-06-30
• Primary Completion: 2020-09-09
• Study Completion: 2022-09-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 3159

Inclusion Criteria

• patients admitted within 7 days of acute myocardial ischemic symptoms with a primary clinical diagnosis of AMI, meet Fourth Universal Definition for Myocardial Infarction (2018)

Exclusion Criteria

• Types 4a and type 5 AMI

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Transfer after thrombolysis	thrombolysis	-

Primary Outcome Measures

Name	Time	Method
all-cause death	2 years post discharge	all-cause death

Secondary Outcome Measures

Name	Time	Method
major adverse cardiac events (MACE)	2 years post discharge	recurrent angina, non-fatal myocardial infarction, cardiac failure, malignant arrhythmia, and death from cardiovascular causes

Trial Locations

Locations (1)

The second hospital of Jilin university; 🇨🇳 Changchun, Jilin, China